Navigation Links
PhRMA Statement on Expansion of SCHIP
Date:2/4/2009

WASHINGTON, Feb. 4 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin issued the following statement today regarding the State Children's Health Insurance Program Reauthorization Act:

"President Obama's signing into law an expansion of the State Children's Health Insurance Program (SCHIP) marks a tremendous victory for millions of low-income, uninsured American families and, indeed, for all Americans -- for we are the friends and neighbors of those who will be helped.

"SCHIP is a vital resource for children and families across America and has provided high-quality, comprehensive health insurance coverage to more than seven million low-income children in the past year alone. It provides children important access to quality health care and, with it, peace of mind for their families. That's why PhRMA has long supported reauthorization of SCHIP, and that's why we are pleased that it has been signed into law.

"What's more, the bill signed by President Obama will extend access to SCHIP coverage to an additional 4.1 million children who would otherwise be uninsured. This is an important step toward the goal of helping all American children have access to the high-quality, affordable health care they need.

"In fact, a recent announcement from the Department of Health and Human Services shows how effective SCHIP is at providing care to low-income children. According to HHS, 7.4 million children were enrolled in SCHIP in 2008, a 4 percent increase over the previous year.

"This is important progress, as a healthy child is more likely to be a healthy adult, and SCHIP provides essential resources to keep children healthy.

"Such challenges will only increase in the future if we don't take steps to confront it now. According to the Centers for Disease Control and Prevention, the share of children who are overweight has more than tripled in the U.S. over the last three decades. Other estimates suggest that by 2015, 24 percent of children in the U.S. will be overweight or obese. This reality leads to additional problems: a recent study predicted that one in three children born in 2000 will develop diabetes over the course of his or her life.

"That's why PhRMA is a proud member of the Partnership to Fight Chronic Disease, and that's why we applaud the efforts of Congress and President Obama to make this victory happen. Every child deserves a chance to be healthy, and SCHIP will help to provide that opportunity."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $44.5 billion in 2007 in discovering and developing new medicines. Industry-wide research and investment reached a record $58.8 billion in 2007.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For information on the dangers of imported drugs, visit: http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PhRMA Statement on Enactment of FDA Legislation
2. PhRMA Celebrates 20th Anniversary of Discoverers Award
3. PhRMA Applauds House Committee on Foreign Affairs Commitment to Continuing Efforts to Fight AIDS, Tuberculosis, and Malaria Epidemics
4. Richard T. Clark Elected PhRMA Board Chairman
5. PhRMA Revised Marketing Code Reinforces Commitment to Responsible Interactions With Healthcare Professionals
6. Johnson & Johnson Announces Commitment To Adopt Revised PhRMA Marketing Code for Responsible Interactions With Healthcare Professionals
7. Eisai Renews Its Commitment to Responsible Healthcare Community Interactions in Accordance with the Revised PhRMA Marketing Code
8. Revised PhRMA Marketing Code Calls for More Educational Materials for Health Care Providers and Staff - Anatstat Health Education Can Help
9. DIA/FDA/PhRMA Drug Safety Conference: Planning the Lifecycle of Safety Evaluation
10. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
11. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... , ... June 27, 2016 , ... Quality metrics are ... in many ways they remain in the eye of the beholder, according to experts ... publication of The American Journal of Managed Care. For the full issue, click ...
(Date:6/26/2016)... Clarkston, Michigan (PRWEB) , ... June 26, 2016 ... ... respect to fertility once they have been diagnosed with endometriosis. These women need ... but they also require a comprehensive approach that can help for preservation of ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/24/2016)... June 24, 2016  Consumers have taken a ... have placed more emphasis on patient outcomes. ... programs in the pharmaceutical industry have evolved beyond ... pharmaceutical companies are focusing on becoming more patient-oriented ... products and services that improve health. ...
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
Breaking Medicine Technology: